September 19, 2025

Sironax Named to 2025 Endpoints 11 List of the Most Promising Biotech Startups

Read More
July 10, 2025

Comments from Dr. Shefali Agarwal, President and CEO, on Agreement with Novartis

Read More
July 9, 2025

Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform While Retaining Rights to Advance Selected Therapeutic Assets

Read More
June 30, 2025

Sironax Accelerates Global Expansion

Read More
May 8, 2025

Sironax Story | Build the Bridge From Bench to Bedside for Degenerative Diseases

Read More
April 22, 2025

Sironax Completed Phase I study for SIR2501

Read More